0

Liver Disease Collection
 41-60 of 964 Articles
Articles |  4 December 2007 FREE
Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir: A Randomized Trial
Henry L.Y. Chan, MD; E. Jenny Heathcote, MD; Patrick Marcellin, MD; et al.
Ann Intern Med. 2007;147(11):745-754. doi:10.7326/0003-4819-147-11-200712040-00183
Editorials |  4 December 2007 FREE
Evolution of Therapy for Chronic Hepatitis B: Progressing from the Simple to the Complex
Jordan J. Feld, MD; Marc G. Ghany, MD
Ann Intern Med. 2007;147(11):806-808. doi:10.7326/0003-4819-147-11-200712040-00014
Articles |  20 November 2007
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis
Bart J. Veldt, MD; E. Jenny Heathcote, MD; Heiner Wedemeyer, MD; et al.
Ann Intern Med. 2007;147(10):677-684. doi:10.7326/0003-4819-147-10-200711200-00003
Ideas and Opinions |  3 July 2007
The Natural History and Treatment of Chronic Hepatitis B: A Critical Evaluation of Standard Treatment Criteria and End Points
Ching-Lung Lai, MD; Man-Fung Yuen, MD, PhD
Ann Intern Med. 2007;147(1):58-61. doi:10.7326/0003-4819-147-1-200707030-00010
Articles |  15 May 2007
Differences in Access to Liver Transplantation: Disease Severity, Waiting Time, and Transplantation Center Volume
Jawad Ahmad, MD; Cindy L. Bryce, PhD; Thomas Cacciarelli, MD; et al.
Ann Intern Med. 2007;146(10):707-713. doi:10.7326/0003-4819-146-10-200705150-00004
Articles |  1 May 2007
Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C–Related Hepatocellular Carcinoma: A Prospective Study
Kazuki Ikeda, MD; Hiroyuki Marusawa, MD, PhD; Yukio Osaki, MD; et al.
Ann Intern Med. 2007;146(9):649-656. doi:10.7326/0003-4819-146-9-200705010-00008
Medicine and Public Policy |  16 May 2006
A Framework for Management of Hepatitis C in Prisons
Anne C. Spaulding, MD, MPH; Cindy M. Weinbaum, MD, MPH; Daryl T.-Y. Lau, MD, MPH; et al.
Ann Intern Med. 2006;144(10):762-769. doi:10.7326/0003-4819-144-10-200605160-00010
Editorials |  16 May 2006
Hepatitis C: A Bitter Harvest
Jules L. Dienstag, MD
Ann Intern Med. 2006;144(10):770-771. doi:10.7326/0003-4819-144-10-200605160-00011
Articles |  21 March 2006 FREE
Brief Communication: Severe Hepatotoxicity of Telithromycin: Three Case Reports and Literature Review
Kimberly D. Clay, MD, MPH; John S. Hanson, MD; Scott D. Pope, PharmD; et al.
Ann Intern Med. 2006;144(6):415-420. doi:10.7326/0003-4819-144-6-200503210-00121
Editorials |  21 March 2006
Telithromycin
Michelle Turner, PharmD; G. Ralph Corey, MD; Elias Abrutyn, MD
Ann Intern Med. 2006;144(6):447-448. doi:10.7326/0003-4819-144-6-200603210-00014
Articles |  21 February 2006
Zoledronic Acid Prevents Bone Loss after Liver Transplantation: A Randomized, Double-Blind, Placebo-Controlled Trial
Bronwyn A.L. Crawford, MBBS, PhD; Cherie Kam, MPH, GDipScMed; Julie Pavlovic, RN; et al.
Ann Intern Med. 2006;144(4):239-248. doi:10.7326/0003-4819-144-4-200602210-00005
Articles |  17 January 2006
Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis
Eric F.H. van Bommel, MD, PhD; Tadek R. Hendriksz, MD; Antonius W.L.C. Huiskes, MD; et al.
Ann Intern Med. 2006;144(2):101-106. doi:10.7326/0003-4819-144-2-200601170-00007
Articles |  15 November 2005
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Masahide Hamaguchi, MD; Takao Kojima, MD; Noriyuki Takeda, MD; et al.
Ann Intern Med. 2005;143(10):722-728. doi:10.7326/0003-4819-143-10-200511150-00009
Editorials |  15 November 2005
Dangerous Liaisons: The Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Elizabeth E. Powell, MBBS, PhD; Julie R. Jonsson, BSc, PhD; Andrew D. Clouston, MBBS, PhD
Ann Intern Med. 2005;143(10):753-754. doi:10.7326/0003-4819-143-10-200511150-00015
Current Clinical Issues |  21 June 2005
Liver Cancer on the Rise
Jennifer Fisher Wilson
Ann Intern Med. 2005;142(12_Part_1):1029-1032. doi:10.7326/0003-4819-142-12_Part_1-200506210-00024
Articles |  17 May 2005
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
Fasiha Kanwal, MD, MSHS; Ian M. Gralnek, MD, MSHS; Paul Martin, MD; et al.
Ann Intern Med. 2005;142(10):821-831. doi:10.7326/0003-4819-142-10-200505170-00007
Reviews |  15 March 2005
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Karl E. Anderson, MD; Joseph R. Bloomer, MD; Herbert L. Bonkovsky, MD; et al.
Ann Intern Med. 2005;142(6):439-450. doi:10.7326/0003-4819-142-6-200503150-00010
Articles |  15 February 2005
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
Henry Lik-Yuen Chan, MD; Nancy Wai-Yee Leung, MD; Alex Yui Hui, MB, BChir; et al.
Ann Intern Med. 2005;142(4):240-250. doi:10.7326/0003-4819-142-4-200502150-00006
Articles |  2 March 2004
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Stephanos J. Hadziyannis, MD; Hoel Sette, MD; Timothy R. Morgan, MD; et al.
Ann Intern Med. 2004;140(5):346-355. doi:10.7326/0003-4819-140-5-200403020-00010
Reviews |  2 March 2004
Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?
Stefan Zeuzem, MD
Ann Intern Med. 2004;140(5):370-381. doi:10.7326/0003-4819-140-8-200404200-00009
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)